AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21726428 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal persons)
Number of subjects: 46
Study 21726428 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost and Diclofenac
Number of subjects: 46
Study 19386061 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition-oriented breast self-examination intervention program involving lectures, demonstrations, practice with models, and feedback.
Number of subjects: 48
Study 19386061 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 48
Study 17662129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus (Elidel cream 1%)
Number of subjects: 3
Study 17662129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 16098458 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of imatinib daily
Number of subjects: 946
Study 16098458 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-over to high-dose imatinib after progression on 400 mg
Number of subjects: 946
Study 16098458 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-over to high-dose imatinib
Number of subjects: 946
Study 12044735 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger children (4-5 years)
Number of subjects: 293
Study 12044735 — intervention group
Group type: EXPERIMENTAL
Intervention: Older children (7-8 years)
Number of subjects: 293
Study 12044735 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 293
Study 10749030 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat milk (0.75 liters/day for 5 weeks)
Number of subjects: 66
Study 10749030 — intervention group
Group type: COMPARATOR
Intervention: Control drink (rice milk, 0.75 liters/day for 5 weeks)
Number of subjects: 66
Study 8583020 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery and scaling and root planning with Augmentin
Number of subjects: 40
Study 8583020 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery and scaling and root planning with tetracycline
Number of subjects: 40
Study 8583020 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery and scaling and root planning with ibuprofen
Number of subjects: 40
Study 8583020 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery and scaling and root planning with placebo
Number of subjects: 40
Study 8583020 — intervention group
Group type: COMPARATOR
Intervention: Poor response group
Number of subjects: 40
Study 2407812 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant endocrine therapy (tamoxifen 20 mg/d and low-dose prednisone 7.5 mg/d for one year)
Number of subjects: 320
Study 2407812 — intervention group
Group type: COMPARATOR
Intervention: Observation (no adjuvant therapy)
Number of subjects: 320
Study 7355185 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 compound CS‐US trials
Number of subjects: 36
Study 7355185 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 compound CS‐US trials
Number of subjects: 36
Study 7355185 — intervention group
Group type: COMPARATOR
Intervention: 30 compound CS presentations and 30 shock stimuli (Control group)
Number of subjects: 36
Study 31504064 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile children (5-14 months)
Number of subjects: 584
Study 31504064 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible dirt on finger pads
Number of subjects: 584
Study 31504064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirty fingernails
Number of subjects: 584
Study 31504064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirty fingerpads and palms
Number of subjects: 584
Study 31504064 — intervention group
Group type: EXPERIMENTAL
Intervention: All three types of observations (dirty fingernails, fingerpads, palms)
Number of subjects: 584
Study 28982775 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual asthma clinic (VAC) with 8-monthly outpatient visits and monthly web-based monitoring
Number of subjects: 210
Study 28982775 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual asthma clinic (VAC)
Number of subjects: 210
Study 28982775 — intervention group
Group type: COMPARATOR
Intervention: Usual care with 4-monthly outpatient visits
Number of subjects: 210
Study 25611932 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail-delivered intervention focused on diet and physical activity
Number of subjects: 47
Study 25611932 — intervention group
Group type: COMPARATOR
Intervention: General health information (Control)
Number of subjects: 47
Study 23424242 — intervention group
Group type: EXPERIMENTAL
Intervention: IVPCA-cryo group
Number of subjects: 50
Study 23424242 — intervention group
Group type: COMPARATOR
Intervention: IVPCA group
Number of subjects: 50
Study 21555750 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 120
Study 21555750 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study 19556410 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate oral care
Number of subjects: 56
Study 19556410 — intervention group
Group type: COMPARATOR
Intervention: Oral care without antiseptic
Number of subjects: 56
Study 17549773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on educational session (lecture and practice on mannequins)
Number of subjects: 150
Study 17549773 — intervention group
Group type: COMPARATOR
Intervention: Usual training (control group)
Number of subjects: 150
Study 15081447 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2 to 3 cups of brewed coffee)
Number of subjects: 77
Study 11394242 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (ten exercises, three sets of ten repetitions maximum, 2 min rest between sets)
Number of subjects: 10
Study 11394242 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 10
Study 9517746 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal drainage
Number of subjects: 319
Study 9517746 — intervention group
Group type: COMPARATOR
Intervention: No abdominal drainage
Number of subjects: 319
Study 9517746 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 319
Study 9517746 — intervention group
Group type: COMPARATOR
Intervention: Nonsuction drainage
Number of subjects: 319
Study 8288717 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg E3 suppository
Number of subjects: 28
Study 8288717 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 28
Study 3056503 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 176
Study 3056503 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 176
Study 15840256 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg once daily for 1 week
Number of subjects: 58
Study 15840256 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg once daily for 1 week
Number of subjects: 58
Study 15840256 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 58
Study 15840256 — intervention group
Group type: COMPARATOR
Intervention: Control group (stable coronary heart disease)
Number of subjects: 58
Study 31894102 — intervention group
Group type: EXPERIMENTAL
Intervention: Helminth infection
Number of subjects: 0
Study 31894102 — intervention group
Group type: EXPERIMENTAL
Intervention: Deworming (1 year after treatment)
Number of subjects: 0
Study 31894102 — intervention group
Group type: COMPARATOR
Intervention: No helminth infections (urban Indonesians)
Number of subjects: 0
Study 30857843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon (CB) ablation
Number of subjects: 58
Study 30857843 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation
Number of subjects: 58
Study 30857843 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CB and RF ablation
Number of subjects: 58
Study 28509934 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency, deep, repetitive transcranial magnetic stimulation (drTMS) of the medial prefrontal cortex for 16 weeks, 3 times a week during intensive phase and once a week during maintenance phase.
Number of subjects: 9
Study 28509934 — intervention group
Group type: COMPARATOR
Intervention: Sham condition of drTMS.
Number of subjects: 9
Study 28509934 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of FOG severity and cognitive scores.
Number of subjects: 9
Study 26277774 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (75 mg)
Number of subjects: 12
Study 26277774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23443509 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecare
Number of subjects: 2600
Study 23443509 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 2600
Study 23443509 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary metrics
Number of subjects: 2600
Study 21292253 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocelectomy
Number of subjects: 72
Study 21292253 — intervention group
Group type: COMPARATOR
Intervention: Healthy fertile men (Control)
Number of subjects: 72
Study 19224846 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine, methoxypolyethylene glycosylated liposomal doxorubicin, or topotecan
Number of subjects: 4312
Study 19224846 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel (reference arm)
Number of subjects: 4312
Study 16823646 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient procedure (OP)
Number of subjects: 50
Study 16823646 — intervention group
Group type: COMPARATOR
Intervention: Overnight stay (OS)
Number of subjects: 50
Study 12732605 — intervention group
Group type: EXPERIMENTAL
Intervention: MRA (spironolactone)
Number of subjects: 134
Study 10924732 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplementation (1 g/day)
Number of subjects: 101
Study 10924732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 9311486 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg.kg-1 in 250 mL of saline
Number of subjects: 10
Study 9311486 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study 8286026 — intervention group
Group type: EXPERIMENTAL
Intervention: Epi-Lock dressing
Number of subjects: 38
Study 8286026 — intervention group
Group type: COMPARATOR
Intervention: moist saline dressing
Number of subjects: 38
Study 3724308 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 10
Study 3724308 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1.0 mg
Number of subjects: 10
Study 3724308 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1.5 mg
Number of subjects: 10
Study 3724308 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2.0 mg
Number of subjects: 10
Study 3724308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 26655892 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape of a Black boy displaying ADHD-related behaviors
Number of subjects: 131
Study 26655892 — intervention group
Group type: COMPARATOR
Intervention: Videotape of a White boy displaying ADHD-related behaviors
Number of subjects: 131
Study 28242554 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic therapeutic tape
Number of subjects: 21
Study 28242554 — intervention group
Group type: COMPARATOR
Intervention: No-tape control
Number of subjects: 21
Study 23563342 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided
Number of subjects: 20
Study 23563342 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation coupled with O-arm-guided
Number of subjects: 20
Study 24007748 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide (4 mg/day on days 1-21) plus low-dose dexamethasone (40 mg/day on days 1, 8, 15, and 22)
Number of subjects: 455
Study 24007748 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (40 mg/day on days 1-4, 9-12, and 17-20)
Number of subjects: 455
Study 24007748 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide plus low-dose dexamethasone
Number of subjects: 455
Study 24007748 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone
Number of subjects: 455
Study 20215781 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (Vi-E) treatment on the blood-side layer of a synthetic polysulfone dialyzer
Number of subjects: 20
Study 20215781 — intervention group
Group type: COMPARATOR
Intervention: Polysulfone (PS) dialyzer without Vi-E treatment
Number of subjects: 20
Study 20215781 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary analysis including baseline PTH and Vi-E levels
Number of subjects: 20
Study 18416259 — intervention group
Group type: EXPERIMENTAL
Intervention: Array SA40N lens
Number of subjects: 30
Study 18416259 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSTOR lens
Number of subjects: 30
Study 18416259 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis ZM001 lens
Number of subjects: 30
Study 16609356 — intervention group
Group type: EXPERIMENTAL
Intervention: [99mTc]pertechnetate salivary gland scintigraphy (SGS) after intravenous injection of 370 MBq
Number of subjects: 93
Study 12617384 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonophoresis of naproxen (10%)
Number of subjects: 61
Study 12617384 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis of naproxen (10%)
Number of subjects: 61
Study 10720082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 45-2081 (50 mg, single intravenous injection)
Number of subjects: 7
Study 8874590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (20 micrograms)
Number of subjects: 26
Study 8874590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 1571644 — intervention group
Group type: EXPERIMENTAL
Intervention: Office system intervention
Number of subjects: 98
Study 1571644 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 98
Study 1571644 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention mentioned)
Number of subjects: 98
Study 3882614 — intervention group
Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 350
Study 3882614 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 350
Study 30033755 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation (RAS) training for 24 weeks
Number of subjects: 60
Study 30033755 — intervention group
Group type: COMPARATOR
Intervention: Control group discontinued RAS training between weeks 8 and 16
Number of subjects: 60
Study 28205476 — intervention group
Group type: EXPERIMENTAL
Intervention: CTS‐6 quantitative diagnostic tool
Number of subjects: 0
Study 28205476 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CTS‐6 tool)
Number of subjects: 0
Study 26503485 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted clinical decision support system and performance-based incentives
Number of subjects: 36
Study 26503485 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention facilities
Number of subjects: 36
Study 24448692 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiroxostat 160 mg/day
Number of subjects: 123
Study 24448692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 21781149 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 181
Study 21781149 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 181
Study 19071226 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg BID
Number of subjects: 270
Study 19071226 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 microg BID
Number of subjects: 270
Study 16835772 — intervention group
Group type: EXPERIMENTAL
Intervention: Buttress group
Number of subjects: 14
Study 16835772 — intervention group
Group type: COMPARATOR
Intervention: Tension band group
Number of subjects: 14
Study 15821394 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/RTV) (300/100 mg) once daily
Number of subjects: 358
Study 15821394 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/RTV) (400/100 mg) twice daily
Number of subjects: 358
Study 15821394 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/saquinavir (ATV/SQV) (400/1200 mg) once daily
Number of subjects: 358
Study 15821394 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/RTV) and Atazanavir/saquinavir (ATV/SQV)
Number of subjects: 358
Study 15821394 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/RTV)
Number of subjects: 358
Study 17313001 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling method for regulating the spleen and stomach
Number of subjects: 120
Study 17313001 — intervention group
Group type: COMPARATOR
Intervention: Acupoints around the eye (control group)
Number of subjects: 120
Study 10224988 — intervention group
Group type: EXPERIMENTAL
Intervention: Education through monthly newsletters
Number of subjects: 1226
Study 10224988 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus incentives for participation
Number of subjects: 1226
Study 10224988 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 1226
Study 8695740 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision and primary suture
Number of subjects: 120
Study 8695740 — intervention group
Group type: COMPARATOR
Intervention: Open excision
Number of subjects: 120
Study 2069516 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant inhalation (1 ml; 10 mg per milliliter)
Number of subjects: 11
Study 2069516 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 11
Study 6337003 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 8
Study 31601619 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanon
Number of subjects: 463
Study 31601619 — intervention group
Group type: EXPERIMENTAL
Intervention: Nexplanon
Number of subjects: 463
Study 29579846 — intervention group
Group type: EXPERIMENTAL
Intervention: HTK + UW solution
Number of subjects: 40
Study 29579846 — intervention group
Group type: COMPARATOR
Intervention: HTK alone
Number of subjects: 40
Study 26728882 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination HIV-prevention intervention
Number of subjects: 200
Study 26728882 — intervention group
Group type: COMPARATOR
Intervention: Matched pairs recruitment process
Number of subjects: 200
Study 26728882 — intervention group
Group type: EXPERIMENTAL
Intervention: RDS-2 method
Number of subjects: 200
Study 26728882 — intervention group
Group type: EXPERIMENTAL
Intervention: RDS-diagnostic statistics
Number of subjects: 200
Study 24501376 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level probes embedded within natural scenes with semantic manipulation via stimulus inversion or reversed playback
Number of subjects: 0
Study 24501376 — intervention group
Group type: COMPARATOR
Intervention: Control condition with semantic interpretation intact
Number of subjects: 0
Study 21848929 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (ET) on bicycle ergometer 2 × 20 min
Number of subjects: 32
Study 21848929 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS) of leg extensors (10 Hz for 60 min)
Number of subjects: 32
Study 21848929 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) without exercise
Number of subjects: 32
Study 21143943 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week home-based program consisting of 150 minutes per week of tailored moderate physical activity
Number of subjects: 230
Study 21143943 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 230
Study 18173139 — intervention group
Group type: EXPERIMENTAL
Intervention: Erzhi Tiangui Granule (ETG) combined with Western medicine
Number of subjects: 80
Study 18173139 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 80
Study 15309433 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO) 40 mL/day
Number of subjects: 22
Study 15309433 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil (ROO) 40 mL/day
Number of subjects: 22
Study 12126548 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH), 4.5 U Bid for 5‐7 days
Number of subjects: 60
Study 10401999 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (0.25 I)
Number of subjects: 160
Study 10401999 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (1 I)
Number of subjects: 160
Study 10401999 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (1.5 I)
Number of subjects: 160
Study 7586252 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 15 g infused over 24 hours
Number of subjects: 27
Study 30809633 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 196
Study 30809633 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 196
Study 31160243 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (200 mg/day)
Number of subjects: 204
Study 31160243 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-RES group)
Number of subjects: 204
Study 28222178 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) meal
Number of subjects: 24
Study 28222178 — intervention group
Group type: COMPARATOR
Intervention: High-Monounsaturated Fat (HMF) meal
Number of subjects: 24
Study 25892271 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide along with intensified antianginal therapy (group A)
Number of subjects: 461
Study 25892271 — intervention group
Group type: COMPARATOR
Intervention: Intensified antianginal therapy alone (group B)
Number of subjects: 461
Study 22867975 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (12.5 mg) administered via intra-articular injections
Number of subjects: 27
Study 21193172 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 30 mg
Number of subjects: 24
Study 21193172 — intervention group
Group type: COMPARATOR
Intervention: Atomoxetine (ATM) 60 mg
Number of subjects: 24
Study 21193172 — intervention group
Group type: COMPARATOR
Intervention: Citalopram (CIT) 30 mg
Number of subjects: 24
Study 21193172 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC) (dextrose)
Number of subjects: 24